PEPITEM 'replacement therapy' shows potential for early-stage inflammatory arthritis

PEPITEM 'replacement therapy' shows potential for early-stage inflammatory arthritis

Scientists investigating the naturally occurring immunopeptide PEPITEM have shown reductions in arthritic joint swelling to a degree comparable to the current standard of care, and reduce the inflammatory changes that cause joint damage.

If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on the star and choose us from your favorites.

If you want to read more Like this articles, you can visit our Science category.

Source

Leave a Reply

Your email address will not be published. Required fields are marked *